Wearable and implantable microfluidic technologies for future digital therapeutics.
Wearable microfluidic tech enhances real-time biosensing and drug delivery, paving the way for personalized digital therapeutics. 💉📱
August 20, 2025
Follow us
latest articles
Discover the newest research about AI innovations in ⌚ Wearables.
Passive Sensing for Mental Health Monitoring Using Machine Learning With Wearables and Smartphones: Scoping Review.
Passive sensing & ML enhance mental health monitoring. 42 studies show 92.16% accuracy in anxiety detection. 📊🧠
August 15, 2025
Internet of things enabled deep learning monitoring system for realtime performance metrics and athlete feedback in college sports.
IoT-enabled deep learning model achieves 93.45% accuracy in real-time athlete performance tracking. 📊🏃♂️
August 5, 2025
Alder Hey Introduces AI Strategy for Enhanced Children’s Healthcare
Alder Hey’s AI strategy aims to enhance children’s healthcare with virtual assistants, predictive models, and improved diagnostics. 🤖👶
August 2, 2025
Access HSC and BearingPoint Collaborate on Virtual Ward Integration
Access HSC and BearingPoint collaborate to enhance virtual ward integration, aiming for better patient care and coordination. 🏥🤝
August 1, 2025
Optimizing beat-wise input for arrhythmia detection using 1-D convolutional neural networks: A real-world ECG study.
Optimizing arrhythmia detection: 94.82% accuracy with 4 beats using 1-D CNNs in real-world ECG studies. 📊❤️
June 25, 2025
Enhancing Surgical Precision: A Systematic Review of Wearable Medical Devices for Assisted Surgery.
Wearable medical devices enhance surgical precision with AI, improving outcomes. Key challenges include data privacy and interoperability. 🤖🔍
June 24, 2025
Predicting chronic pain using wearable devices: a scoping review of sensor capabilities, data security, and standards compliance.
Wearable devices show potential in chronic pain prediction, but data security and model integration need improvement. 📈🔍
June 6, 2025
Creatine kinase in prostate cancer: A biosensor-driven diagnostic paradigm.
Innovative CK-BB biosensors show over 85% accuracy in prostate cancer detection! ⚗️📊 Rapid, sensitive diagnostics on the horizon!
June 1, 2025
Hinge Health Raises $437.3 Million in Initial Public Offering
Hinge Health raises $437.3 million in IPO, offering digital musculoskeletal care and innovative health solutions. 📈💼
May 23, 2025